tirzepatide san francisco To keep pounds off, patients may need to continue taking weight loss drug, study suggests Tirzepatide for Medical Weight Loss

The SURMOUNT-4 trial assessed the weight maintenance with tirzepatide and had also two periods: a 36-week open-label lead-in period during which all participants took tirzepatide, followed by a 52-week double-blind treatment period during which participants were randomised to either continue on tirzepatide or switch to placebo

Sakaki et al., 1986)

In this case, Zepbound mimics two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)

Workup with hematology included extensive testing for possible hypercoagulable conditions

This consistency is important for maintaining steady progress and avoiding fluctuations in treatment outcomes

Pregnancy or planning to become pregnant